BCPC BALCHEM CORP
BCPC financial statements, revenue, balance sheet, cash flow, and SEC filings
▼ Company Profile
▼ Key Metrics (TTM)
As of Sep 30, 2026Sources and calculation details
Reported values are preserved. Derived values use the listed inputs; unavailable inputs remain blank.
Field-level sources for this historical record are unavailable until it is rebuilt from SEC facts.
| Metric | FY2025 📄 | FY2024 📄 | FY2023 📄 |
|---|---|---|---|
| Income Statement | |||
| REVENUE | |||
| Revenue | $1.04B | $953.68M | $922.44M |
| Cost of Revenue | $666.53M | $617.48M | $620.38M |
| Gross Profit | $370.63M | $336.21M | $302.06M |
| OPERATING EXPENSES | |||
| R&D Expense | $18.51M | $16.79M | $15.05M |
| SG&A Expense | $67.42M | $67.59M | $53.42M |
| Other Operating Expenses (derived) | $75.37M | $68.92M | $74.40M |
| Operating Income | $209.33M | $182.91M | $159.19M |
| NON-OPERATING INCOME / EXPENSE | |||
| Other Income/Expense | $-77.00K | $72.00K | $681.00K |
| Income Tax | $44.19M | $37.98M | $28.72M |
| Net Income | $154.85M | $128.48M | $108.54M |
| PER SHARE & SUPPLEMENTAL | |||
| Diluted EPS | $4.75 | $3.93 | $3.35 |
| Diluted Shares | 32.60M | 32.72M | 32.45M |
| EBITDA | $255.02M | $230.88M | $214.13M |
| Depreciation & Amortization | $45.69M | $47.97M | $54.94M |
| Balance Sheet | |||
| ASSETS | |||
| Cash & Equivalents | $74.57M | $49.52M | $64.45M |
| Accounts Receivable | $143.60M | $119.66M | $125.28M |
| Inventory | $131.45M | $130.80M | $109.52M |
| Other Current Assets | $6.22M | $5.74M | $7.19M |
| Current Assets | $365.61M | $313.77M | $314.24M |
| PP&E (Net) | $306.65M | $282.15M | $276.04M |
| Goodwill | $816.38M | $780.03M | $778.91M |
| Intangible Assets | $132.99M | $132.48M | $191.21M |
| Other Noncurrent Assets | $18.13M | $17.32M | $16.95M |
| Noncurrent Assets | $1.32B | $1.26B | $1.28B |
| Total Assets | $1.69B | $1.58B | $1.60B |
| LIABILITIES | |||
| Current Liabilities | $176.38M | $157.69M | $148.49M |
| Noncurrent Liabilities | $252.46M | $267.77M | $394.74M |
| Total Liabilities | $428.84M | $425.46M | $543.23M |
| EQUITY | |||
| Common Stock | $2.14M | $2.17M | $2.15M |
| Additional Paid-in Capital | $92.33M | $174.00M | $145.65M |
| Retained Earnings | $1.12B | $997.49M | $897.49M |
| Accumulated OCI | $41.55M | $-23.75M | $8.69M |
| Total Equity | $1.26B | $1.15B | $1.05B |
| Total Liabilities & Equity | $1.69B | $1.58B | $1.60B |
| SUPPLEMENTAL | |||
| Shares Outstanding | 32.06M | 32.53M | 32.25M |
| Check: A − (L + E + Temp. Equity) | - | - | - |
| Cash Flow Statement | |||
| Cash from Operations | $216.56M | $182.00M | $183.76M |
| Capital Expenditures | - | - | - |
| Cash from Investing | $-43.89M | $-59.74M | $-34.81M |
| Cash from Financing | $-152.81M | $-133.82M | $-153.32M |
| Free Cash Flow | - | - | - |
| Beginning Cash (CFS) | $49.52M | $64.45M | $66.56M |
| Net Change in Cash | $19.86M | $-11.55M | $-4.37M |
| Effect of FX on Cash | $5.20M | $-3.38M | $2.26M |
| Calculated Ending Cash | $74.57M | $49.52M | $64.45M |
| Cash per BS | $74.57M | $49.52M | $64.45M |
| Cash scope difference (CFS − BS) | - | - | - |
| Cash per CFS | $74.57M | $49.52M | $64.45M |
Create a free account to see full history, quarterly data, charts, CSV downloads, and API access.
Create Free Account Log InQuarterly data and charts require a free account
Get access to 8 quarters of data, interactive charts, CSV downloads, and API access.
▼ Frequently Asked Questions
What is BALCHEM CORP's annual revenue?
BALCHEM CORP reported $1.11B in revenue for trailing twelve months (ending September 2026). Revenue figures are sourced from the company's annual SEC EDGAR filing.
Is BALCHEM CORP profitable?
Yes. BALCHEM CORP reported $170.85M in net income for trailing twelve months. Profitability data is based on the company's most recent annual report filed with the SEC.
Fundamentals Hub